Latest Cash Runway News

Admiralty Resources has commissioned the transmission line at its Mariposa Iron Ore Project, securing direct grid power and reducing reliance on costly fuel generators.

Cynata Therapeutics has secured A$1.5 million through an institutional placement priced at a 22.5% discount, aiming to extend its cash runway ahead of pivotal Phase 3 and Phase 2 trial results expected in May and June 2026.

White Cliff Minerals has recommenced drilling at its Rae Copper Project, delivering high-grade copper-silver results and metallurgical testwork supporting simplified processing. The company agreed to sell its Great Bear Project for A$5.8 million, refocusing resources on Rae.

Aldoro Resources has defined high-priority gold targets at its Damara Gold Project and confirmed significant rare earth and associated mineralisation at Kameelburg, with drilling and metallurgical progress underpinning its dual-commodity strategy.

FBR Limited secured its first overseas Mantis welding robot sale, launched the Firehawk refractory robot, and expanded its Wall as a Service footprint in Victoria, while navigating a cash balance under $700,000.

InteliCare has locked in its largest-ever $8.8 million contract with mecwacare to deploy its AI-driven platform across 22 aged care homes, while appointing Angus Cameron as CEO to spearhead growth.

RocketBoots has secured a significant A$3.3 million activation contract with a tier-one multinational retailer and reported over 50% growth in its early sales pipeline, supported by a strong cash position of A$5 million.

Comet Ridge progresses engineering design and environmental approvals for its Mahalo Gas Project, pushing ahead with the acquisition of Santos’ stake to consolidate full ownership and expand its east coast gas footprint.

Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.

Zimi Limited posted 14% revenue growth and landed its biggest project order to date with Homecorp, while slashing operating costs and launching an AI sales agent.

Marquee Resources has significantly increased its Mt Clement inferred antimony resource and is advancing drilling and strategic partnerships to develop its flagship project.

Rhythm Biosciences marked a pivotal shift from development to commercial diagnostics in Q3 FY26, recording its first ColoSTAT® clinical sale and initiating NHS England evaluation while expanding geneType™ partnerships across Asia and Australia.